Patient & Survivor Care
Latest News
ChatGPT Enhances Readability of Cancer Information for Patients
Before revision, the readability level was that of a university freshman; with ChatGPT revision, it improved to a high school freshman level.
News from the FDA/CDC
FDA Expands Durvalumab Label to Endometrial Cancer
Approval of the new indication was based on the phase 3 DUO-E trial, which included women with newly diagnosed advanced or recurrent dMMR...
Latest News
Surviving to Thriving: Enhancing Quality of Life in Breast Cancer
Up to 90% of early breast cancer survivors experience long-term effects from treatment, which often include fatigue, loss of mobility, chronic...
News from the FDA/CDC
FDA Expands Repotrectinib Label to All NTRK Gene Fusion+ Solid Tumors
The approval was based on a single-arm open-label trial in 88 adults with locally advanced or metastatic NTRK gene fusion solid tumors....
Feature
Engineering Mind Helps Investigator Develop New Cancer Therapies
Leading colorectal cancer investigator Dr. Scott Kopetz discusses his unusual start to medicine and how his engineering background helped him make...
Conference Coverage
Ovarian Cancer Risk Doubled by Estrogen-Only HRT
Long-term follow up in women with hysterectomy included in the WHI reveals significantly more cases of ovarian cancer.
Conference Coverage
Chemo May Benefit Some Older Patients With Metastatic Pancreatic Cancer
Researchers examine real-world outcomes of older adults with untreated metastatic pancreatic cancer.
Conference Coverage
HPV Vaccine Offers Cancer Protection Beyond Cervical Cancer
A ‘really important study’ extends the information about the impact of getting vaccinated against HPV, says expert.
From the Journals
Are Children Born Through ART at Higher Risk for Cancer?
A slight increase in the risk for leukemia was observed in children conceived through IVF or ICSI.
Latest News
About 20% of Breast Cancer Survivors Gain Excess Weight
After adjustment for confounding factors, younger age at breast cancer diagnosis and lower baseline weight were the strongest predictors of more...
Conference Coverage
T-DXd Moves Toward First Line for HER2-Low Metastatic BC
New results from DESTINY trials support use of the antibody-drug conjugate earlier in the treatment algorithm for cancers expressing even the...